Found: 19
Select item for more details and to access through your institution.
Cost-Effectiveness of 12 First-Line Treatments for Patients With Advanced EGFR Mutated NSCLC in the United Kingdom and China.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.819674
- By:
- Publication type:
- Article
Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1191480
- By:
- Publication type:
- Article
The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.
- Published in:
- Quality of Life Research, 2018, v. 27, n. 11, p. 2799, doi. 10.1007/s11136-018-1928-y
- By:
- Publication type:
- Article
Is bad living better than good death? Impact of demographic and cultural factors on health state preference.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 4, p. 769, doi. 10.1007/s10557-021-07173-3
- By:
- Publication type:
- Article
Angiotensin II Inhibits Adipogenic Differentiation and Promotes Mature Adipocyte Browning through the Corepressor CtBP1.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3131, doi. 10.3390/biomedicines10123131
- By:
- Publication type:
- Article
Comparative Proteomic Analysis of tPVAT during Ang II Infusion.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1820, doi. 10.3390/biomedicines9121820
- By:
- Publication type:
- Article
RhoGDI1-Cdc42 Signaling Is Required for PDGF-BB-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Neointima Formation.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1169, doi. 10.3390/biomedicines9091169
- By:
- Publication type:
- Article
Cost-utility analysis of insulin degludec versus insulin glargine in the treatment of type 2 diabetes mellitus patients in China.
- Published in:
- Chinese Journal of Diabetes Mellitus, 2022, v. 14, n. 9, p. 968, doi. 10.3760/cma.j.cn115791-20220527-00238
- By:
- Publication type:
- Article
Cost- effectiveness analysis of switch from premix human insulin to biphasic insulin aspart 30 in Chinese patients with type 2 diabetes mellitus.
- Published in:
- Chinese Journal of Diabetes Mellitus, 2015, v. 7, n. 12, p. 741, doi. 10.3760/cma.j.issn.1674-5809.2015.12.006
- By:
- Publication type:
- Article
Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 7, p. 3334, doi. 10.1007/s12325-022-02185-3
- By:
- Publication type:
- Article
Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn's Disease in China.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 8, p. 4233, doi. 10.1007/s12325-021-01806-7
- By:
- Publication type:
- Article
Response Letter to "Letter: Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China".
- Published in:
- 2020
- By:
- Publication type:
- letter
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-effectiveness analysis of 11 pharmacotherapies for recurrent glioblastoma in the USA and China.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241264727
- By:
- Publication type:
- Article
RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5398, doi. 10.3390/ijms21155398
- By:
- Publication type:
- Article
Rural population's preferences matter: a value set for the EQ-5D-3L health states for China's rural population.
- Published in:
- 2022
- By:
- Publication type:
- journal article